We are looking for children to join a Crohn’s disease (CD) medical research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or moderate to severe IBD (including associated symptoms such as rectal bleeding, joint pain, abdominal pain, chronic fatigue and/or anemia), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Is your child currently experiencing CD and UC flare-ups? Local Crohn’s disease (CD) trial is testing a potential new medication to see if it may reduce stomach pain, diarrhea, constant need to poop, malnutrition, and/or canker sores associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the Crohn’s disease (CD) trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

We are looking for 2 to 17 years old to join a Crohn’s disease clinical research to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or moderate to severe Crohn’s disease (including associated symptoms such as diarrhea, joint pain, rectal pain, malnutrition and/or canker sores), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing UC flare-ups? Local Crohn’s disease clinical research is testing a potential new medication to see if it may reduce tiredness, stomach pain, bloody stool, malnutrition, and/or eye pain associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the Crohn’s disease clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

We are looking for teen to join a Crohn’s disease trial to help us discover more about treating ulcerative colitis (UC). If you are looking for a potential new treatment option for ulcerative colitis (UC) or moderate to severe UC (including associated symptoms such as chronic diarrhea, perianal fistula, constant need to poop, weight loss and/or canker sores), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your teen may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local medical research study is testing a potential new medication to see if it may reduce chronic diarrhea, mouth sores, cramps, chronic fatigue, and/or anemia associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for young people 2 to 17 years of age to join a UC clinical research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or Crohn’s disease (including associated symptoms such as diarrhea with blood and pus, diarrhea, cramps, frequent fevers and/or anemia), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing UC flare-ups? Local CD trial is testing a potential new medication to see if it may reduce diarrhea with pus, failure to thrive, diarrhea, malnutrition, and/or eye pain associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the CD trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for 2–17 year olds to join a Crohn’s disease (CD) clinical research study to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or ulcerative colitis (including associated symptoms such as rectal pain, growth failure, constant need to poop, chronic fatigue and/or liver disease), consider one of our ICD and UC clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the ICD and UC clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing moderate to severe CD flare-ups? Local Crohn’s disease medical research study is testing a potential new medication to see if it may reduce bloody diarrhea, diarrhea, bloody stool, frequent fevers, and/or joint pain associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the Crohn’s disease medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.